These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4415956)

  • 21. Automation of immune hemolytic and complement reactions by AutoAnalyzer. II.
    Vargues R; Henley W
    Mt Sinai J Med; 1974; 41(3):453-79. PubMed ID: 4134099
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of complement by a substance isolated from human erythrocytes. II. Studies on the site and mechanism of action.
    Hoffmann EM
    Immunochemistry; 1969 May; 6(3):405-19. PubMed ID: 5786934
    [No Abstract]   [Full Text] [Related]  

  • 23. The enzymatic measurement of binding of first component of guinea pig complement with formalized sheep erythrocytes sensitized with rabbit antiserum.
    Mori Y; Kawai N; Koyama J
    J Biochem; 1973 May; 73(5):951-8. PubMed ID: 4737266
    [No Abstract]   [Full Text] [Related]  

  • 24. Resistance of sheep erythrocytes to immune lysis by treatment of the cells with a human erythrocyte extract: studies on the site of inhibition.
    Hoffmann EM; Cheng WC; Tomeu EJ; Renk CM
    J Immunol; 1974 Nov; 113(5):1501-9. PubMed ID: 4424275
    [No Abstract]   [Full Text] [Related]  

  • 25. [The third component of complement and complement receptors (author's transl)].
    Okuda T; Tachibana T
    Tanpakushitsu Kakusan Koso; 1974 Sep; 19(9):657-67. PubMed ID: 4215099
    [No Abstract]   [Full Text] [Related]  

  • 26. Anti-complement activity of oleanolic acid: an inhibitor of C3-convertase of the classical complement pathway.
    Kapil A; Sharma S
    J Pharm Pharmacol; 1994 Nov; 46(11):922-3. PubMed ID: 7897600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of the lytic effect of guinea pig complement by rabbit complement.
    Kempf RA; Gigli I; Austen KF
    J Immunol; 1969 Apr; 102(4):795-803. PubMed ID: 5768190
    [No Abstract]   [Full Text] [Related]  

  • 28. Inhibition of complement by a substance isolated from human erythrocytes. I. Extraction from human erythrocyte stromata.
    Hoffman EM
    Immunochemistry; 1969 May; 6(3):391-403. PubMed ID: 5786933
    [No Abstract]   [Full Text] [Related]  

  • 29. The third component of the guinea pig complement system. 3. Effect of inhibitors.
    Shin HS; Mayer MM
    Biochemistry; 1968 Aug; 7(8):3003-6. PubMed ID: 5666767
    [No Abstract]   [Full Text] [Related]  

  • 30. Complement inhibitor(s) released by leukocytes. III. Evidence for a "new" C1 inhibitor in the supernatants of short-term cultures of mouse spleen and thymus cells.
    Bernard A; Boumsell L; Borsos
    J Immunol; 1975 Oct; 115(4):1091-4. PubMed ID: 1176767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of the terminal stage of complement-mediated lysis (reactive lysis) by zinc and copper ions.
    Yamamoto K; Takahashi M
    Int Arch Allergy Appl Immunol; 1975; 48(5):653-63. PubMed ID: 1169223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [C1-inactivator from guinea pig-serum mechanism of action. II. Effect of the inactivator on C1 in its bound form: EAC1, EAC14b and EAC14b2a].
    Loos M
    Z Med Mikrobiol Immunol; 1971; 156(2):221-32. PubMed ID: 5554814
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationship between the membrane inhibitor of reactive lysis and the erythrocyte phenotypes of paroxysmal nocturnal hemoglobinuria.
    Holguin MH; Wilcox LA; Bernshaw NJ; Rosse WF; Parker CJ
    J Clin Invest; 1989 Nov; 84(5):1387-94. PubMed ID: 2478585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of the first component of complement evidence for an internal activation step.
    Loos M; Borsos T; Rapp HJ
    J Immunol; 1972 Mar; 108(3):683-8. PubMed ID: 5011751
    [No Abstract]   [Full Text] [Related]  

  • 35. Reaction mechanisms of nascent C567 (reactive lysis). I. Reaction characteristics for production of EC567 and lysis by C8 and C9.
    Goldman JN; Ruddy S; Austen KF
    J Immunol; 1972 Aug; 109(2):353-9. PubMed ID: 4558539
    [No Abstract]   [Full Text] [Related]  

  • 36. Isolation and characterization of a low molecular weight complement inhibitor present in normal human serum.
    Baker PJ; Osofsky SG
    Clin Exp Immunol; 1981 Mar; 43(3):549-56. PubMed ID: 6912799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sodium azide inhibition of complement-mediated functions.
    Shaw DR; Shaw MW; Hickman SE; Lamon EW; Griffin FM
    Immunology; 1980 Jan; 39(1):53-6. PubMed ID: 7380463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passive hemolysis by serum and cobra venom factor: a new mechanism inducing membrane damage by complement.
    Pickering RJ; Wolfson MR; Good RA; Gewurz H
    Proc Natl Acad Sci U S A; 1969 Feb; 62(2):521-7. PubMed ID: 4978744
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.
    Ruddy S; Austen KF
    J Immunol; 1969 Mar; 102(3):533-43. PubMed ID: 5813010
    [No Abstract]   [Full Text] [Related]  

  • 40. C3-independent immune haemolysis: mechanism of membrane attack complex formation.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Sep; 59(1):147-51. PubMed ID: 3759127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.